7-74338805-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_003388.5(CLIP2):āc.479C>Gā(p.Ser160Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000714 in 1,611,300 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000085 ( 0 hom., cov: 32)
Exomes š: 0.000070 ( 0 hom. )
Consequence
CLIP2
NM_003388.5 missense
NM_003388.5 missense
Scores
11
8
Clinical Significance
Conservation
PhyloP100: 4.27
Genes affected
CLIP2 (HGNC:2586): (CAP-Gly domain containing linker protein 2) The protein encoded by this gene belongs to the family of cytoplasmic linker proteins, which have been proposed to mediate the interaction between specific membranous organelles and microtubules. This protein was found to associate with both microtubules and an organelle called the dendritic lamellar body. This gene is hemizygously deleted in Williams syndrome, a multisystem developmental disorder caused by the deletion of contiguous genes at 7q11.23. Alternative splicing of this gene generates 2 transcript variants. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.3149535).
BS2
High AC in GnomAd4 at 13 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLIP2 | NM_003388.5 | c.479C>G | p.Ser160Cys | missense_variant | 3/17 | ENST00000223398.11 | NP_003379.4 | |
CLIP2 | NM_032421.3 | c.479C>G | p.Ser160Cys | missense_variant | 3/16 | NP_115797.2 | ||
CLIP2 | XM_047420800.1 | c.479C>G | p.Ser160Cys | missense_variant | 3/13 | XP_047276756.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLIP2 | ENST00000223398.11 | c.479C>G | p.Ser160Cys | missense_variant | 3/17 | 5 | NM_003388.5 | ENSP00000223398 | P3 | |
CLIP2 | ENST00000361545.9 | c.479C>G | p.Ser160Cys | missense_variant | 3/16 | 1 | ENSP00000355151 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152210Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
13
AN:
152210
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000407 AC: 10AN: 245710Hom.: 0 AF XY: 0.0000448 AC XY: 6AN XY: 133950
GnomAD3 exomes
AF:
AC:
10
AN:
245710
Hom.:
AF XY:
AC XY:
6
AN XY:
133950
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000699 AC: 102AN: 1458972Hom.: 0 Cov.: 33 AF XY: 0.0000675 AC XY: 49AN XY: 725922
GnomAD4 exome
AF:
AC:
102
AN:
1458972
Hom.:
Cov.:
33
AF XY:
AC XY:
49
AN XY:
725922
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000853 AC: 13AN: 152328Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74482
GnomAD4 genome
AF:
AC:
13
AN:
152328
Hom.:
Cov.:
32
AF XY:
AC XY:
6
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
5
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 09, 2023 | The c.479C>G (p.S160C) alteration is located in exon 3 (coding exon 2) of the CLIP2 gene. This alteration results from a C to G substitution at nucleotide position 479, causing the serine (S) at amino acid position 160 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;.
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Benign
L;L;L
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Uncertain
Sift
Uncertain
D;D;D
Sift4G
Uncertain
T;D;D
Polyphen
D;D;D
Vest4
MutPred
Loss of phosphorylation at S160 (P = 0.0395);Loss of phosphorylation at S160 (P = 0.0395);Loss of phosphorylation at S160 (P = 0.0395);
MVP
MPC
1.6
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at